Claritev annual stock-based compensation
2018
2019
2020
2021
2022
2023
2024
2025
Claritev Stock-Based Compensation Growth & History (CTEV)
Claritev's stock-based compensation was $27.8M for fiscal 2025.
View full Claritev company overviewClaritev annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $27.8M | $1.2M | +4.42% |
| 2024 | 2024-12-31 | $26.6M | $8.6M | +47.88% |
| 2023 | 2023-12-31 | $18.0M | $1.3M | +7.64% |
| 2022 | 2022-12-31 | $16.7M | −$1.3M | −7.06% |
| 2021 | 2021-12-31 | $18.0M | −$388.0M | −95.56% |
| 2020 | 2020-12-31 | $406.1M | $420.9M | — |
| 2019 | 2019-12-31 | −$14.9M | −$19.6M | — |
| 2018 | 2018-12-31 | $4.7M | — | — |
Claritev quarterly stock-based compensation
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.4M | $669,000 | +9.98% |
| Q1 2026 | 2026-03-31 | $6.9M | $566,000 | +8.94% |
| Q4 2025 | 2025-12-31 | $7.8M | $980,000 | +14.38% |
| Q3 2025 | 2025-09-30 | $7.0M | $173,000 | +2.54% |
| Q2 2025 | 2025-06-30 | $6.7M | −$611,000 | −8.35% |
| Q1 2025 | 2025-03-31 | $6.3M | $635,000 | +11.15% |
| Q4 2024 | 2024-12-31 | $6.8M | $2.2M | +46.23% |
| Q3 2024 | 2024-09-30 | $6.8M | $2.0M | +41.01% |
| Q2 2024 | 2024-06-30 | $7.3M | $2.5M | +51.58% |
| Q1 2024 | 2024-03-31 | $5.7M | $2.0M | +54.10% |
| Q4 2023 | 2023-12-31 | $4.7M | −$780,000 | −14.34% |
| Q3 2023 | 2023-09-30 | $4.8M | $771,000 | +18.97% |
| Q2 2023 | 2023-06-30 | $4.8M | $723,000 | +17.62% |
| Q1 2023 | 2023-03-31 | $3.7M | $565,000 | +18.05% |
| Q4 2022 | 2022-12-31 | $5.4M | $625,000 | +12.98% |
| Q3 2022 | 2022-09-30 | $4.1M | −$688,000 | −14.48% |
| Q2 2022 | 2022-06-30 | $4.1M | −$3.4M | −45.09% |
| Q1 2022 | 2022-03-31 | $3.1M | $2.2M | +223.35% |
| Q4 2021 | 2021-12-31 | $4.8M | −$101.6M | −95.47% |
| Q3 2021 | 2021-09-30 | $4.8M | −$257.6M | −98.19% |
| Q2 2021 | 2021-06-30 | $7.5M | −$20.4M | −73.22% |
| Q1 2021 | 2021-03-31 | $968,000 | −$8.4M | −89.66% |
| Q4 2020 | 2020-12-31 | $106.4M | — | — |
| Q3 2020 | 2020-09-30 | $262.4M | — | — |
| Q2 2020 | 2020-06-30 | $27.9M | — | — |
| Q1 2020 | 2020-03-31 | $9.4M | — | — |
Claritev stock-based compensation trends
Over the last five fiscal years, Claritev's stock-based compensation decreased from $406.1M to $27.8M, a change of −$378.2M. The latest reported quarter, Q2 2026, shows $7.4M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Claritev source filings ↗